You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alveolar soft part sarcoma (ASPS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)

Active, not recruiting
Has Results
  • Alveolar Soft Part Sarcoma
  • Soft Tissue Sarcomas
  • Miami, Florida
    University of Miami
Dec 29, 2022

Alveolar Soft Part Sarcoma Trial in Beijing (GB226)

Recruiting
  • Alveolar Soft Part Sarcoma
  • GB226
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 2, 2021

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting
  • Advanced Alveolar Soft Part Sarcoma
  • +3 more
  • Atezolizumab
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jan 28, 2023

Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • +3 more
  • Phoenix, Arizona
  • +22 more
Nov 1, 2022

Sarcoma, Alveolar Soft Part Trial run by the NCI (AZD2171)

Active, not recruiting
Has Results
  • Sarcoma, Alveolar Soft Part
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 11, 2022

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

Recruiting
  • Soft Tissue Sarcoma
  • +9 more
  • Patient with Soft Tissue Sarcoma
  • Besancon, France
  • +13 more
Oct 11, 2022

Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)

Completed
  • Sarcoma, Clear Cell
  • +3 more
  • GVAX
  • Boston, Massachusetts
  • +1 more
Mar 2, 2021

Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

Recruiting
  • Sarcoma
  • +3 more
  • Isolated Limb Infusion
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 21, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Sarcoma,Soft Tissue Trial in Barcelona, Madrid, Zaragoza (Selinexor)

Recruiting
  • Sarcoma,Soft Tissue
  • Barcelona, Spain
  • +5 more
Nov 16, 2021

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
May 9, 2022

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)

Active, not recruiting
  • Sarcoma
  • +10 more
  • Hypofractionated radiotherapy
  • Hyperthermia
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021

Sarcoma Trial (Camrelizumab and Apatinib)

Unknown status
  • Sarcoma
  • Camrelizumab and Apatinib
  • (no location specified)
Jun 23, 2020

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
  • +7 more
  • Bologna, Italy
  • +12 more
Nov 10, 2021

Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

Recruiting
  • Metastatic Solid Tumor
  • +6 more
  • Surufatinib and Tislelizumab _ Part 1
  • Surufatinib and Tislelizumab _ Part 2
  • Tucson, Arizona
  • +17 more
Apr 1, 2022

Solid Tumors, Colorectal Cancer, Breast Cancer Trial in Canada, United States (LY2880070, Gemcitabine)

Completed
  • Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Soft Tissue Sarcoma Trial in Münster (Dacarbazine, onfekafusp alfa)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +15 more
Dec 22, 2022

Soft Tissue Sarcoma Trial (Cadonilimab)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Cadonilimab
  • (no location specified)
Dec 9, 2022

Soft Tissue Sarcoma Trial in Boston (Ferumoxytol)

Withdrawn
  • Soft Tissue Sarcoma
  • Boston, Massachusetts
  • +3 more
Oct 14, 2020

Novel Applications for Sarcoma Assessment

Not yet recruiting
  • Sarcoma
  • Quantitative MRI
  • Reproducibility study
  • (no location specified)
Oct 2, 2023

Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

Recruiting
  • Sarcoma,Soft Tissue
  • Tenerife, Canarias, Spain
  • +10 more
Oct 27, 2023

Renal Cell Carcinoma and Adrenal Carcinoma

Recruiting
  • Renal Cell Carcinoma
  • Adrenal Carcinoma
  • VETC evaluation
  • Rozzano, MI, Italy
    Humanitas Clinical and Research Hospital
Feb 9, 2021